XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Shareholders' Equity (Tables)
3 Months Ended
Mar. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of Stock Options Activity

For the three months ended March 31, 2021 and 2020, there was no compensation expense related to stock options. As of December 31, 2019, all stock options had vested. No stock options were granted, exercised, or expired during the three months ended March 31, 2021 or 2020. Presented below is information about stock options outstanding and exercisable as of March 31, 2021 and December 31, 2020:

 

    March 31, 2021     December 31, 2020  
    Shares     Price     Shares     Price  
                         
Stock options outstanding and exercisable     31,367     $ 64.78       31,367     $ 64.78  
                                 

Schedule of Stock Options Outstanding and Exercisable

The following table summarizes information for stock options outstanding and for stock options exercisable at March 31, 2021:

 

Options Outstanding     Options Exercisable  
      Exercise Price     Weighted     Remaining           Weighted  
Number of     Range    

Average

Exercise

   

Contractual

Term

    Number of    

Average

Exercise

 
Shares     Low     High     Price     (years)     Shares     Price  
                                       
16,500     $ 7.20     $ 11.60     $ 10.00       6.5       16,500     $ 10.00  
10,622       90.00       124.80       106.20       3.1       10,622       106.20  
2,913       139.20       171.00       147.39       1.2       2,913       147.39  
1,332       226.20       251.40       232.48       2.7       1,332       232.48  
                                                   
31,367     $ 7.20     $ 251.40     $ 64.78       4.7       31,367     $ 64.78  

Schedule of Non-vested Time-based Restricted Stock Awards

The following table presents the changes in non-vested time-based restricted stock awards to all employees and directors for the three months ended March 31, 2021:

 

    Shares    

Weighted-Avg.

Grant Date

Fair Value

per Share

 
       
Non-vested restricted stock at December 31, 2020     71,000     $ 4.89  
Granted     150,000     $ 4.72  
Vested     (47,000 )   $ 4.89  
Non-vested at March 31, 2021     174,000     $ 4.75